Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902485 · ClinicalTrials.gov registry record · Phase 4
Study of Immediate Start of Progestin Contraceptives in Medical Abortion
A Phase 4 study of Contraception, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- Phase 4
- Development phase
- 937
- Enrollment target
- 8
- Study locations
NCT01902485 is a Phase 4 study of Contraception that has completed, run by Gynuity Health Projects. The registered enrollment target is 937 participants, above the 442-participant average among 72 other Contraception trials with a reported enrollment target (112% higher). The trial reports 8 study locations across 5 states.
The verdict
NCT01902485, a Phase 4 study of Contraception, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 937 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.
Conditions Studied
Interventions
- OTHER Timing of Contraceptive Initiation in Medical Abortion
Study Locations (8)
California
- Planned Parenthood of the Pacific Southwest - Chula Vista
- Planned Parenthood Northern California - Eureka
Massachusetts
- Boston Medical Center - Boston
- Planned Parenthood League of Massachusetts - Boston
Other
- Centro de Salud Beatriz Velasco de Aleman - Mexico City
- Centro de Salud Santa Catarina - Mexico City
Connecticut
- Planned Parenthood of Southern New England - Stamford
Maryland
- Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 937 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01902485
The ClinicalTrials.gov registry entry for NCT01902485 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 937 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 442-participant average among 72 other Contraception trials with a reported enrollment target (112% higher). The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Timing of Contraceptive Initiation in Medical Abortion is the first listed.
NCT01902485 reports 8 study locations spanning 5 distinct geographic areas - top geographies include California, Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT01902485 about?
NCT01902485 is a clinical study titled "Study of Immediate Start of Progestin Contraceptives in Medical Abortion". This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.
What is the current status of trial NCT01902485?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 937 participants. The study started on 2013-07. Estimated completion is 2015-12.
What conditions does trial NCT01902485 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT01902485?
The interventions under investigation include: Timing of Contraceptive Initiation in Medical Abortion (OTHER).
Who is sponsoring clinical trial NCT01902485?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01902485 being conducted?
This trial has 8 study locations across California, Connecticut, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
RECRUITING · Phase 4
-
Etonogestrel Implant as Emergency Contraception
RECRUITING · Phase 4
-
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
ACTIVE NOT RECRUITING · Phase 4
-
Impact of Combined Hormonal Contraceptives on UPA
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.